Objectives. Key Elements. ICAHN Targeted Focus Areas: Staff Competency and Education Quality Processes and Risk Management 5/20/2014
|
|
- Joella Dickerson
- 5 years ago
- Views:
Transcription
1 ICAHN Targeted Focus Areas: Staff Competency and Education Quality Processes and Risk Management Matthew Fricker, RPh, MS, FASHP Program Director, ISMP Rebecca Lamis, PharmD, FISMP Medication Safety Analyst, ISMP May 22, 2014 Objectives Discuss strategies to enhance the content of orientation and educational programs and staff competency evaluations Recognize the importance of a culture of safety within your organization and provide methods for identifying and analyzing risk Review the ICAHN aggregate self assessment results for these areas 2 Key Elements Key Element Mean % VI Drug Device Acquisition, Use, Monitoring 51% VIII Staff Competency and Education 55% I Patient Information 56% II Drug Information 56% IX Patient Education 63% X Quality Processes and Risk Management 63% IV Drug Labeling, Packaging, Nomenclature 65% III Communication of Drug Orders and Other Drug Info. 70% V Drug Standardization, Storage, Distribution 73% VII Environmental Factors, Workflow, Staffing Patterns 81% Total 63% 3 1
2 Rank Order of Error Reduction Strategies Strategy Fail safes and constraints Forcing functions Automation and computerization Standardization Redundancies Reminders and checklists Rules and policies Education and information Suggestions to be more vigilant Power (Leverage) High ( Blunt end ) Medium Low ( Sharp end ) 4 Staff Competency and Education Although staff education is a weak error reduction strategy alone, it plays an important role when combined with system based error reduction strategies Activities with the highest leverage include: Ongoing assessment of healthcare providers baseline competencies Education about new medications, non formulary medications, high alert medications, and medication error prevention 5 Problems with Staff Competency and Education Inadequate orientation process and baseline competency validation Competencies inconsistent throughout organization Lack of standardized, interdisciplinary education Inconsistent credentialing, training, and certification Lack of sharing information about errors (internal and external), their causes, and prevention 6 2
3 Core Characteristic #14: Practitioners receive orientation to medication use and undergo competency evaluations (57%) 7 What Should be Included in Orientation? Understanding of the entire medication use process Nurses spend time in the pharmacy Pharmacists spend time on patient care units Specific processes and procedures related to the provision of care, treatment, and services Technology training and assessment of use Medication errors and risk reduction strategies Staff is oriented to the key safety content before providing care, treatment, and services 8 Nurses Spend Time in the Pharmacy 173 During orientation, nurses spend time in the pharmacy (and with clinical pharmacists) to become familiar with the order entry and/or verification process, drug preparation and dispensing, availability of drug information resources, ways to access these resources, and various medication safety initiatives. 43% 50% 7% 9 3
4 Pharmacists Spend Time in Care Units 174 During orientation, pharmacists spend time in patient care units to become familiar with drug prescribing practices, unit stock storage conditions, medication administration procedures, and patient education processes. 29% 29% 43% 10 Pharmacists Participate in Medical Staff Orientation 175 Pharmacists actively participate in the orientation process for new medical staff (including medical students, medical residents, and attending physicians). 57% 29% 14% 11 Teamwork Training 183 The organization provides formal teamwork training (e.g., TeamSTEPPS) to all staff that incorporates elements of information sharing, conflict resolution, communication and teamwork skills, and clarification of team roles and responsibilities. 71% 21% 7% 12 4
5 Medication Error Information Provided During Orientation 172 During orientation and on a routine basis, staff participating in the medication use process, receive information about the hospital s actual error experiences as well as published errors that have occurred in other facilities; and they are educated about system based strategies to reduce the risk of such errors. 36% 50% 14% 13 Specialty Pharmacists/Nurses Undergo Training 176 All prescribers, pharmacists, and nurses who work in specialty areas (e.g., critical care, pediatrics, oncology) undergo extensive training and/or obtain certification if available in that specialty before working independently. 7% 57% 36% 14 Qualified and Trained Specialty Pharmacists 167 The organization has an adequate complement of well qualified and trained pharmacists to work in specialty areas or provide services to specialty populations (e.g., critical care, pediatric, neonatal, and oncology patients) that represent a substantial portion of the organization's patient population. 0% 21% 79% 15 5
6 Qualified and Trained Specialty Nurses 168 The organization has an adequate complement of well qualified and trained nurses to provide care to specialty populations (e.g., critical care, pediatric, neonatal, and oncology patients) that represent a substantial portion of the organization's patient population. 7% 7% 86% 16 Baseline Competency Evaluation 171 All new staff participating in the medication use process, including agency staff, undergo baseline competency evaluation before working independently. 29% 14% 57% 17 Topics to Include in Orientation and Baseline Competency Safe practices around medication use At risk behaviors Technology Error reporting/risk identification 18 6
7 Topics to Include in Orientation and Baseline Competency System based causes of medication errors High leverage strategies for risk reduction Examples of medication errors Internally reported Externally reported 19 Examples of Competencies for Nurses Consistently measure and document height and weight using the metric system (only) Demonstrate ability to communicate effectively, e.g., SBAR (situation, background, assessment, recommendation) i.e., verbalize the importance of sharing essential patient information between practitioner groups 20 Examples of Competencies for Nurses Order clarification process Utilize drug information resources as necessary Consistently use two unique patient identifiers Understand and utilize the correct procedure for an independent double check 21 7
8 Examples of Competencies for Pharmacists Verify all orders using the patient s complete profile before entering new orders or adjusting current medications Utilize laboratory parameters to evaluate the proper dosing of drug therapy Recognize appropriate (and inappropriate) therapy for patients based on their disease states and past history 22 Examples of Competencies for Pharmacists Clarify any incomplete or inappropriate orders with the prescriber Complete all steps in the checking process for IV preparations Additional checks required for high alert products? Technology Compounders Robotics Carousels 23 Examples of Competencies for Prescribers Need for complete orders Avoidance of dangerous abbreviations and dose expressions for all orders Use of mg/kg and total dose for pediatric/neonatal orders Formulary control Benefits of standardization Technology CPOE 24 8
9 Examples of At Risk Behaviors Accepting incomplete orders (verbal and written) Only repeating back telephone orders (not writing down/reading back) Administering medications without orders Not taking the MAR to the ADC or bedside Borrowing another patient's medications Not labeling syringes, bowels, etc. Mathematical calculations of doses not independently checked Use of dangerous abbreviations 25 Items on Error Reporting Organization s definition of a medication error What is reportable in your organization? Sentinel event Medication errors (reaching the patient) Close calls Error reporting procedures Reporting mechanism 26 Items on Error Reporting Methods for responding to errors Root cause analysis Proactive risk reduction activity (FMEA) Error reduction strategies How information is used 27 9
10 Core Characteristic #15: Provide ongoing education about medication error prevention and the safe use of drugs to staff (53%) 28 Identifying and Reducing Risk 194 Senior leaders, management, and frontline staff receive formal training in identifying risk within the system and incorporating high leverage errorreduction strategies to help eliminate the risk. 36% 36% 29% 29 Human Factors 193 Human factors and the principles of error reduction (e.g., standardization, use of constraints, redundancy for critical functions) are introduced during practitioner orientation, and used as the foundation for an annual mandatory educational program for all practitioners involved in the medication use process. 57% 29% 14% 30 10
11 Widespread Education 190 When errors occur, educational efforts are widespread among all practitioners who could make a similar error, rather than remedial and directed at only those practitioners who were involved in an error. 21% 36% 43% 31 Ongoing Medication Error Information 186 Practitioners receive ongoing information about medication errors occurring within the organization, error prone conditions, errors occurring in other healthcare facilities, and strategies to prevent such errors. 14% 43% 43% 32 Methods of Education Periodic medication safety tips via Safety updates on the intranet or a medication safety website Storyboards or other poster formats to describe medication safety initiatives and results (often used at an annual skills day/employee updates) 33 11
12 Methods of Education Communication logs used to share safety tips in patient care areas Videos and computer based training courses Weekly multidisciplinary safety rounds with frontline staff and management involvement Simulation exercises 34 Simulations/Role Playing of Error Prone Conditions 192 Simulations of error prone conditions (e.g., problematic medication packages and labels, mock transcription/order entry of problematic orders) and/or role playing (e.g., to teach effective communication skills, inquiry skills, conflict resolution) are used as methodologies to orient and educate practitioners and other staff about medication/patient safety. 71% 29% 0% 35 Examples of Topics for Staff Education Safety strategies with high alert medications, for example opioids Opioid equianalgesic dosing (e.g., HYDROmorphone) Transdermal patch safety PCA safety New drugs added to the formulary Practice guidelines for using newly implemented technology safely 36 12
13 Key Elements Key Element Mean % VI Drug Device Acquisition, Use, Monitoring 51% VIII Staff Competency and Education 55% I Patient Information 56% II Drug Information 56% IX Patient Education 63% X Quality Processes and Risk Management 63% IV Drug Labeling, Packaging, Nomenclature 65% III Communication of Drug Orders and Other Drug Info. 70% V Drug Standardization, Storage, Distribution 73% VII Environmental Factors, Workflow, Staffing Patterns 81% Total 63% 37 Culture eats strategy for lunch everyday! That s the way we do things around here. Organizational safety culture is the most critical, underlying predictor of accomplishments related to safety. 38 Culture of Safety Achievement of sustainable medication safety goals requires lasting culture change Two strong predictors that healthcare workers will adopt patient safety behaviors Observed behaviors of professional peers Genuine belief in the safety outcomes of the behaviors Work in progress in most organizations Marathon not a sprint, but sense of urgency needed 39 13
14 Leaders Demonstrate Commitment to Patient Safety There is a visible commitment to patient safety within the organization that is evident in the behaviors of hospital leaders and managers. The Board of Trustees/Directors actively demonstrates its commitment to patient safety (and safe medication practices) by approving a safety plan, rewarding practitioner error reporting, approving system design enhancements, including technology, that are likely to reduce errors, and incorporating patient safety and quality as a routine and significant component of each board meeting. 0% 43% 57% 7% 43% 50% 40 Safety Structure Components Culture Medication safety committee Strategic plan Medication Safety Practitioner 41 Factors Affecting Error Reporting Culture Anonymously survey practitioners Provides valuable insight Identify strengths and weaknesses in current culture Level of anxiety and fear with making errors and reporting error Ease of reporting errors and receiving feedback Online incident reporting Hotline available Timely feedback; follow up is key to any system 42 14
15 Culture Surveys 220 Practitioners are anonymously surveyed at least annually to assess the organization s safety culture. 64% 29% 7% 215 Practitioners and other staff report and openly discuss errors without embarrassment or fear of reprisal from the hospital/organization. Scoring guideline: If possible, choose A through E based on staff surveys as noted in item 220 7% 36% 57% 43 Internally Reported Errors are Analyzed 234 A convened interdisciplinary team, which includes at a minimum, risk management/quality improvement professionals, pharmacists, nurses, physicians, clinical information technology staff, and hospital leadership, meets at least monthly to review internal medication error/hazard reports, sentinel events, and other medication safety data, to identify the system based causes of error, and to facilitate the implementation of system design enhancements that make it difficult or impossible for practitioners to err. 14% 36% 50% 44 Feedback about Reported Errors 244 Prescribers, pharmacists, and nurses are provided with regular feedback about reported errors, hazardous situations, and error reduction strategies that are being implemented. 7% 50% 43% 45 15
16 Tip of the Iceberg Incident reports (Medication errors reported) Retrospective analysis Observation (Medication errors occurring) 46 Not Just Using Error Reports to Measure Medication Safety 247 An effective means of measuring medication safety (e.g., random chart review using triggers, tracking risk priority numbers from FMEAs, observational methods of error detection, measuring compliance with new medication protocols, drug use evaluations), which does not rely on practitioner reported data, has been designed and implemented to uncover systembased problems and to demonstrate sustained improvement after implementation of risk reduction strategies. 14% 64% 21% 47 Methods of Data Collection Proactive risk assessment Self assessments Failure Mode and Effects Analysis (FMEA) External sources of data ISMP s Quarterly Action Agenda The Joint Commission Sentinel Event Alert FDA alerts Concurrent risk assessment Pharmacy interventions Triggers and markers 48 16
17 Medication Use Process is Analyzed 233 The entire medication use process is analyzed at least annually (e.g., using a proactive risk assessment tool such as this self assessment) to identify potential risk factors for medication errors. 50% 43% 7% 49 Team Analyzes Outside Errors 240 A convened interdisciplinary team routinely analyzes and uses published error experiences from other organizations to assess the organization s vulnerability to similar errors and proactively target improvements in the medication use process. 43% 29% 29% 50 Dispensing and Prescribing Errors are Analyzed 242 Drug selection, preparation, and labeling errors identified during routine checking processes are reported and collected for the purpose of identifying system design issues and developing error prevention strategies. 14% 29% 57% 243 Prescribing errors that are detected by pharmacists and nurses are recorded, analyzed, and used in conjunction with medical staff quality improvement activities for system redesign 0% 50% 50% 51 17
18 Use of Triggers 241 In addition to practitioner reporting systems, computer markers or triggers for selected drug orders (such as antidotes) and laboratory tests (such as aptt greater than 100) are used to enhance detection of potential adverse drug events (both medication errors and adverse drug reactions). 14% 64% 21% 52 Methods of Data Collection Retrospective risk assessment Observational methodology WalkRounds Data from technology Smart pumps, ADCs, pharmacy system Chart reviews Rapid Response Teams Fall data Internal, voluntary reporting Close calls and good catches 53 Leadership WalkRounds 228 Senior leaders (administrative staff, board members when possible) participate in frequent, structured visits (e.g., WALKROUNDS to patient care units, the pharmacy, and laboratories to talk to frontline staff about safety and quality issues, learn first hand about day to day challenges that staff face when providing care and services, and show their support for staff reported errors. 29% 43% 29% 54 18
19 Off the Record Discussions 232 Trusted nurse, pharmacist, and physician representatives facilitate periodic, announced, focus groups of frontline practitioners for off the record discussions to learn about perceived problems and risks with the medication use system. 36% 36% 29% 55 Questions? 56 19
Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center
Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center at the Maritime Institute Improving Staff Education
More informationObjectives. Demographics: Type and Services 1/22/2014. ICAHN Aggregate Results. ISMP Medication Safety Self Assessment for Hospitals
ICAHN Aggregate Results ISMP Medication Safety Self Assessment for Hospitals Matthew Fricker, RPH, MS, FASHP Rebecca Lamis, PharmD, FISMP January 23, 2014 1 Objectives Report the demographic characteristics
More informationMEDICATION SAFETY SELF-ASSESSMENT FOR LONG-TERM CARE ONTARIO SUMMARY. April 2009 September 2012
MEDICATION SAFETY SELF-ASSESSMENT FOR LONG-TERM CARE ONTARIO SUMMARY April 2009 September 2012 Institute for Safe Medication Practices Canada Institut pour l utilisation sécuritaire des médicaments du
More informationManaging Pharmaceuticals to Reduce Medication Errors August 26, 2003
Managing Pharmaceuticals to Reduce Medication Errors August 26, 2003 Susan M. Proulx, Pharm.D. President, Med-E.R.R.S. Subsidiary of ISMP (www.med-errs.com) Mission of ISMP Translate errors into education
More informationReducing the risk of serious medication errors in community pharmacy practice
Reducing the risk of serious medication errors in community pharmacy practice Eastern Medicaid Pharmacy Administrators Association (EMPAA) November 1, 2017 Newport, Rhode Island Michael R. Cohen, RPh,
More informationReport on the. Results of the Medication Safety Self- Assessment for Long Term Care. Ontario s Long-Term Care Homes
Report on the Results of the Medication Safety Self- Assessment for Long Term Care by Ontario s Long-Term Care Homes Report Submitted to: Ministry of Health And Long-Term Care Prepared by: ISMP Canada
More informationMedication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety
Medication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety Background The Institute of medicine (IOM) estimates that 1.5 million preventable Adverse Drug Events (ADE) occur
More informationAPPENDIX 8-2 CHECKLISTS TO ASSIST IN PREVENTING MEDICATION ERRORS
APPENDIX 8-2 CHECKLISTS TO ASSIST IN PREVENTING MEDICATION ERRORS Use the following checklists in the appropriate areas of your office, facility or practice to assist in preventing medications errors:
More informationIMPACT OF TECHNOLOGY ON MEDICATION SAFETY
Continuous Quality Improvement IMPACT OF Steven R. Abel, PharmD, FASHP TECHNOLOGY ON Nital Patel, PharmD. MBA MEDICATION SAFETY Sheri Helms, PharmD Candidate Brian Heckman, PharmD Candidate Ismaila D Badjie
More informationIntroducing ISMP s New Targeted Best Practices for
Introducing ISMP s New Targeted Best Practices for 2018-2019 Darryl S. Rich, PharmD, MBA, FASHP Medication Safety Specialist Institute for Safe Medication Practices (ISMP) Horsham, PA 1 Disclosure The
More informationRe-Engineering Medication Processes to Capitalize on Technology. Jane Englebright, PhD, RN Vice President, Quality HCA
Re-Engineering Medication Processes to Capitalize on Technology Jane Englebright, PhD, RN Vice President, Quality HCA Who is HCA? % % % % U.K. % % % Switzerland % %% % % % % % %% % % % % % % % %% % % %
More informationDefinitions: In this chapter, unless the context or subject matter otherwise requires:
CHAPTER 61-02-01 Final Copy PHARMACY PERMITS Section 61-02-01-01 Permit Required 61-02-01-02 Application for Permit 61-02-01-03 Pharmaceutical Compounding Standards 61-02-01-04 Permit Not Transferable
More informationMedication Safety Technology The Good, the Bad and the Unintended Consequences
Medication Safety Technology The Good, the Bad and the Unintended Consequences Michelle Mandrack RN, MSN Director of Consulting Services Matthew Fricker, RPh, MS Program Director 1 Objectives Consider
More informationCulture of Safety: What s in Your Toolbox?
Culture of Safety: What s in Your Toolbox? Kathy Ghomeshi, PharmD, BCPS Medication Safety Specialist Victoria Serrano Adams, PharmD, FASHP, FCSHP Director of Pharmaceutical Services UCSF Medical Center
More informationPractice Spotlight. Children's Hospital Central California Madera, California
Practice Spotlight Children's Hospital Central California Madera, California http://www.childrenscentralcal.org Richard I. Sakai, Pharm.D., FASHP, FCSHP Director of Pharmacy Services IN YOUR VIEW, HOW
More informationSafe Medication Practices
Safe Medication Practices Patient Safety: Preventing Adverse Events OHA Conference Renaissance Toronto Hotel at SkyDome Toronto June 14, 2004 David U President & CEO, ISMP Canada Agenda ISMP Canada Patient
More information(10+ years since IOM)
Medication Errors We're Looking Down the Tunnel and Seeing Light (10+ years since IOM) Michael R. Cohen, RPh, MS, ScD Institute for Safe Medication Practices mcohen@ismp.org 1 Disclosure Information Michael
More information2017 Good Catch Program: Blueprint Companion Guide
2017 Good Catch Program: Blueprint Companion Guide EXECUTIVE SUMMARY The following document provides guidance to accompany the recommended strategies listed within the Blueprint for Success, a comprehensive
More informationCognitive Level Certified Professional in Patient Safety Detailed Content Outline Recall. Total. Application Analysis 1.
Cognitive Level Certified Professional in Patient Safety Detailed Content Outline Recall Application Analysis Total 1. CULTURE 2 12 4 18 A. Assessment of Patient Safety Culture 1. Identify work settings
More informationMedication Safety in LTC. Objectives. About ISMP Canada
Medication Safety in LTC Part II -Vulnerabilities in the Medication Use Process and Strategies to Enhance Medication Safety Lynn Riley, RN ISMP Canada Thursday, October 20, 2011 Objectives At the end of
More informationPHARMACY SERVICES/MEDICATION USE
25.01. 10 Drug Reactions & Administration Errors & Incompatibilities. Drug administration errors, adverse drug reactions and incompatibilities must be immediately reported to the attending physician and
More informationHuman Factors. Frank Federico, RPh. This presenter has nothing to disclose.
Human Factors Frank Federico, RPh This presenter has nothing to disclose. 25 February 2015 Culture Learning System Improvement and Measurement Transparency Continuous Learning Accountability Teamwork &
More informationReport from the Medication Safety Self Assessment (MSSA)
Report from the Medication Safety Self Assessment (MSSA) NSW PUBLIC HOSPITALS Feb 2007 - Nov 2007 2 Report from the Medication Safety Self Assessment (MSSA) NSW PUBLIC HOSPITALS 3 Clinical Excellence Commission
More informationShifting from Blame-&-Shame to a Just-and-Safe Culture
Shifting from Blame-&-Shame to a Just-and-Safe Culture Barb Sproll Medication Safety Pharmacist Winnipeg Regional Health Authority 29 May 2018 Conflict of Interest I have no conflicts to disclose. Objectives:
More informationEnd-to-end infusion safety. Safely manage infusions from order to administration
End-to-end infusion safety Safely manage infusions from order to administration New demands and concerns 56% 7% of medication errors are IV-related. 1 of high-risk IVs are compounded in error. 2 $3.5B
More informationPGY1 Medication Safety Core Rotation
PGY1 Medication Safety Core Rotation Preceptor: Mike Wyant, RPh Hours: 0800 to 1730 M-F Contact: (541)789-4657, michael.wyant@asante.org General Description This rotation is a four week rotation in duration.
More informationTo establish a consistent process for the activity of an independent double-check prior to medication administration, where appropriate.
TITLE INDEPENDENT DOUBLE-CHECK SCOPE Provincial, Clinical DOCUMENT # PS-60-01 APPROVAL LEVEL Senior Operating Officer, Pharmacy Services SPONSOR Provincial Medication Management Committee CATEGORY Patient
More informationImproving Safety Practices Anticoagulation Therapy
Improving Safety Practices Anticoagulation Therapy Katie Cinnamon, PharmD, BCPS Clinical Pharmacist Genesis Medical Center - Davenport Objectives Review background information on medication errors and
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE MEDICATION ORDERS SCOPE Provincial APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Provincial Medication Management Committee PARENT DOCUMENT TITLE, TYPE AND NUMBER Not applicable
More informationPreventing Medical Errors
Presents Preventing Medical Errors Contact Hours: 2 First Published: March 31, 2017 This Course Expires on: March 31, 2019 Course Objectives Upon completion of this course, the nurse will be able to: 1.
More informationHow Pharmacy Informatics and Technology are Evolving to Improve Patient Care
How Pharmacy Informatics and Technology are Evolving to Improve Patient Care HealthcareIS.com 2 Table of Contents 3 Impact of Emerging Technologies 3 CPOE 5 Automated Dispensing Machines 6 Barcode Medication
More informationUNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM
BOARD OF PHARMACY SPECIALTIES CRITICAL CARE PHARMACY SPECIALIST CERTIFICATION CONTENT OUTLINE/CLASSIFICATION SYSTEM FINALIZED SEPTEMBER 2017/FOR USE ON FALL 2018 EXAMINATION AND FORWARD UNDERSTANDING THE
More information3/9/2010. Objectives. Pharmacist Role in Medication Safety and Regulatory Compliance
Pharmacist Role in Medication Safety and Regulatory Compliance Janet Greiwe Vice President, Systems Management Cleveland County Health System Objectives By the end of this presentation, you should be able
More informationOne or More Errors in 67% of the IV Infusions: Insights from a Study of IV Medication Administration
One or More Errors in 67% of the IV Infusions: Insights from a Study of IV Medication Administration Presented by: Marla Husch Northwestern Memorial Hospital Northwestern Memorial Hospital Chicago, Illinois
More informationNeonatal Intensive Care Unit EUHM
Neonatal Intensive Care Unit Rotation @ EUHM Preceptor: Office: Tabitha Carney, PharmD, MBA, MSHA EUHM MOT 3 rd Floor in Special Care Nurseries Hours: 0800-1630 Desk: 404-686-8902 Pager: 12621 EUHM Cell
More informationTo understand the formulary process from the hospital perspective
Formulary Process Christine L. Ahrens, Pharm.D. Cleveland Clinic Cleveland Clinic 2011 Goal and Objectives To understand the formulary process from the hospital perspective p To list the various panels
More informationDepartment of Pharmacy Services PGY1 Residency Program. Residency Manual
Department of Pharmacy Services PGY1 Residency Program Residency Manual 1 TABLE OF CONTENTS I. Introduction II. General Program Goals III. Residency Program Purpose Statement IV. Program s Goals V. Residency
More informationMedication Management Checklist for Supportive Living Early Adopter Initiative. Final Report. June 2013
Medication Management Checklist for Supportive Living Early Adopter Initiative Final Report June 2013 Table of Content Executive Summary... 1 Background... 3 Method... 3 Results... 3 1. Participating
More informationThe Medication Safety Journey Natasha Nicol, Pharm. D., FASHP Director of Medication Safety June 4, 2009
The Medication Safety Journey Natasha Nicol, Pharm. D., FASHP Director of Medication Safety June 4, 2009 About me I am someone s mother, wife, daughter, granddaughter, sister, aunt, cousin and niece. I
More informationstudent interests. The 1. Develop of error schema. develop
Sample Medication Safety APPE Student Rotation Rotation Description The medication safety rotation willl help students become familiar with the key principles utilized in hospitals and health systems to
More informationIntroduction to Pharmacy Practice
Introduction to Pharmacy Practice Learning Outcomes Compare & contrast technician & pharmacist roles Understand licensing, certification, registration terms Describe advantages of formal training for technicians
More informationMedication Safety & Electrolyte Administration. Objectives. High Alert Medications. *Med Safety Electrolyte Administration
Medication Safety & Electrolyte Administration Jennifer Doughty, PharmD PGY2 Pharmacy Resident Emergency Medicine Stormont Vail Health, Topeka, KS Objectives Define and identify high alert medications
More informationMEDICATION USE EFFECTIVE DATE: 06/2003 REVISED: 2/2005, 04/2008, 06/2014
TITLE / DESCRIPTION: SAFETY PROCEDURES FOR MEDICATION USE DEPARTMENT: Pharmacy PERSONNEL: All Pharmacy Personnel EFFECTIVE DATE: 06/2003 REVISED: 2/2005, 04/2008, 06/2014 Leadership and Culture A culture
More informationKeenan Pharmacy Care Management (KPCM)
Keenan Pharmacy Care Management (KPCM) This program is an exclusive to KPS clients as an additional layer of pharmacy benefit management by engaging physicians and members directly to ensure that the best
More information17/06/2014. Clinicians Driving Technology - Developing ST CPOE Practice Guidelines and Supporting Their Adoption. Objectives. Cancer Care Ontario
Objectives Clinicians Driving Technology - Developing ST CPOE Practice Guidelines and Supporting Their Adoption Dr. Vishal Kukreti, MD, FRCPC, MSc Clinical Lead, etools and Technology Cancer Care Ontario
More informationEncouraging pharmacy involvement in pharmacovigilance; an international perspective.
Encouraging pharmacy involvement in pharmacovigilance; an international perspective. Michael R. Cohen, RPh, MS, ScD (hon) DPS (hon) Chairperson, International Medication Safety Network and President, Institute
More informationA Discussion of Medication Error Reduction Strategies
A Discussion of Medication Error Reduction Strategies By: Donald L. Sullivan, R.Ph., Ph.D. Program Number: 071067-011-01-H05 C.E.U.s: 0.1 Contact Hours: 1 hour Release Date: 4/1/11 Expiration Date: 4/1/14
More informationDISPENSING BY REGISTERED NURSES (RNs) EMPLOYED WITHIN REGIONAL HEALTH AUTHORITIES (RHAs)
2017 DISPENSING BY REGISTERED NURSES (RNs) EMPLOYED WITHIN REGIONAL HEALTH AUTHORITIES (RHAs) This Interpretive Document was approved by ARNNL Council in 2017 and replaces Dispensing by Registered Nurses
More informationSHRI GURU RAM RAI INSTITUTE OF TECHNOLOGY AND SCIENCE MEDICATION ERRORS
MEDICATION ERRORS Patients depend on health systems and health professionals to help them stay healthy. As a result, frequently patients receive drug therapy with the belief that these medications will
More informationThe Colorado ALTO Project
Using Alternatives to Opioids (ALTOs) in Hospital Emergency Departments PRE-LAUNCH CHECKLIST Based on the 2017 Opioid Prescribing & Treatment Guidelines Colorado ALTO Project Champion Sets the direction
More informationLegislating Patient Safety: The California Experience. October 2003
Legislating Patient Safety: The California Experience October 2003 The Problem: Preventable medical errors are a huge and largely invisible cause of death in California and nationwide. In CA, an estimated
More informationOverview of the Leapfrog CPOE Evaluation Tool. An educational update to the HIMSS EIS Steering Committee August 13, 2009
Overview of the Leapfrog CPOE Evaluation Tool An educational update to the HIMSS EIS Steering Committee August 13, 2009 1 Overview What is the CPOE Evaluation Tool? Development of the Tool Why is Tool
More informationTo describe the process for the management of an infusion pump involved in an adverse event or close call.
TITLE INFUSION PUMPS FOR MEDICATION & PARENTERAL FLUID ADMINISTRATION SCOPE Provincial, Clinical DOCUMENT # PS-70-01 APPROVAL LEVEL Executive Leadership Team SPONSOR Provincial Medication Management Committee
More informationBETA HEALTHCARE GROUP
BETA Healthcare Group is focused on improving reliability and reducing risk exposure in emergency departments. BETA provides our member hospitals and medical groups the opportunity for significant reduction
More informationExample of a Health Care Failure Mode and Effects Analysis for IV Patient Controlled Analgesia (PCA) Failure Modes (what might happen)
Prescribing Assess patient Choose analgesic/mode of delivery Prescribe analgesic Institute for Safe Medication Practices Example of a Health Care and Effects Analysis for IV Patient Controlled Analgesia
More informationCompounded Sterile Preparations Pharmacy Content Outline May 2018
Compounded Sterile Preparations Pharmacy Content Outline May 2018 The following domains, tasks, and knowledge statements were identified and validated through a role delineation study. The proportion of
More informationAchieving safety in medication management through barcoding technology
Achieving safety in medication management through barcoding technology Kara Marx, RN, FACHE, FHIMSS Vice President of Information Services Sharp Healthcare. SESSION OBJECTIVES Describe the primary activities
More information2018 LEAPFROG HOSPITAL SURVEY ORGANIZATIONAL BINDER
2018 LEAPFROG HOSPITAL SURVEY ORGANIZATIONAL BINDER TABLE OF CONTENTS Section # Tab # Overview 1 Section 1: Basic Hospital Information 2 Section 2: Medication Safety CPOE 3 Section 3: Inpatient Surgery
More informationTo prevent harm to patients from adverse medication events involving high-alert medications.
TITLE MANAGEMENT OF HIGH-ALERT MEDICATIONS DOCUMENT # PS-46-01 PARENT DOCUMENT LEVEL LEVEL 1 PARENT DOCUMENT TITLE Management of High-alert Medications Policy APPROVAL LEVEL Alberta Health Services Executive
More informationBest Practices and Performance Measures for Systemic Treatment Computerized Prescriber Order Entry Systems (ST CPOE) in Chemotherapy Delivery
Best Practices and Performance Measures for Systemic Treatment Computerized Prescriber Order Entry Systems (ST CPOE) in Chemotherapy Delivery Dr. Vishal Kukreti, MD, FRCPC, MSc Clinical Lead, Systemic
More informationIntroduction. Medication Errors. Objectives. Objectives. January What is a Medication Error? Define medication errors/variances
Medication Errors Earlene Spence, Pharm.D., Miami VA Healthcare System Neena John, Pharm.D., Miami VA Healthcare System Eva Moreira, Pharm.D., Miami VA Healthcare System Chantal Chan, Pharm.D., Miami VA
More informationRequired Organizational Practices Resources for 2016
Required Organizational Practices Resources for 2016 ROPs Tests for Compliance Things to Consider Available Resources CLIENT IDENTIFICATION Working in partnership with clients and families, at least two
More informationUNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016 Department Name: Department of Pharmacy Department Director: Steve Rough, MS,
More informationFrom Big Data to Big Knowledge Optimizing Medication Management
From Big Data to Big Knowledge Optimizing Medication Management Session 157, March 7, 2018 Dave Webster, RPh MSBA, Associate Director of Pharmacy Operations, URMC Strong Maria Schutt, EdD, Director Education
More informationImproving the Patient Experience Through Pharmacy
Rick Burnett Chief Operating Officer Kenneth Maxik Director, Patient Safety & Pharmacy Compliance Improving the Patient Experience Through Pharmacy August 19, 2015 Speakers Rick Burnett, PharmD, FACHE
More informationNEW JERSEY. Downloaded January 2011
NEW JERSEY Downloaded January 2011 SUBCHAPTER 29. MANDATORY PHARMACY 8:39 29.1 Mandatory pharmacy organization (a) A facility shall have a consultant pharmacist and either a provider pharmacist or, if
More informationCritical Access Hospitals Site Visit Summary Tom Johns, PharmD, BCPS Director, Pharmacy Services UF Health Shands Hospital
Critical Access Hospitals Site Visit Summary 2014 2015 Tom Johns, PharmD, BCPS Director, Pharmacy Services UF Health Shands Hospital 2014 2015 13 Critical Access Hospitals (CAH) Site Visits Compounded
More informationCommunication and Teamwork for Patient Safety 1.0 Contact Hour Presented by: CEU Professor
Communication and Teamwork for Patient Safety 1.0 Contact Hour Presented by: CEU Professor 7 www.ceuprofessoronline.com Copyright 8 2008 The Magellan Group, LLC All Rights Reserved. Reproduction and distribution
More informationCHAPTER 9 PERFORMANCE IMPROVEMENT HOSPITAL
CHAPTER 9 PERFORMANCE IMPROVEMENT HOSPITAL PERFORMANCE IMPROVEMENT Introduction to terminology and requirements Performance Improvement Required (Board of Pharmacy CQI program, The Joint Commission, CMS
More informationRunning head: MEDICATION ERRORS 1. Medications Errors and Their Impact on Nurses. Kristi R. Rittenhouse. Kent State University College of Nursing
Running head: MEDICATION ERRORS 1 Medications Errors and Their Impact on Nurses Kristi R. Rittenhouse Kent State University College of Nursing MEDICATION ERRORS 2 Abstract One in five medication dosages
More informationProfiles in CSP Insourcing: Tufts Medical Center
Profiles in CSP Insourcing: Tufts Medical Center Melissa A. Ortega, Pharm.D., M.S. Director, Pediatrics and Inpatient Pharmacy Operations Tufts Medical Center Hospital Profile Tufts Medical Center (TMC)
More informationManaging Treatment With Oral Oncology Medications. An Educational Toolkit for Health Care Providers
Managing Treatment With Oral Oncology Medications An Educational Toolkit for Health Care Providers Acknowledgment Novartis Pharmaceuticals Corporation would like to thank Jody Pelusi, PhD, FNP, AOCNP,
More informationObjective Competency Competency Measure To Do List
2016 University of Washington School of Pharmacy Institutional IPPE Checklist Institutional IPPE Team Contact Info: Kelsey Brantner e-mail: ippe@uw.edu phone: 206-543-9427; Jennifer Danielson, PharmD e-mail:
More informationMedication Errors An Opportunity to Improve
FSHP Medication Errors An Opportunity to Improve Laura Monroe-Duprey, BS Pharm, PharmD Joanie Spiro Stevens, PharmD, BCPS Disclosure Laura Monroe-Duprey - I do not have (nor does any immediate family member
More informationThe Joint Commission Medication Management Update for 2010
Learning Objectives The Joint Commission Medication Management Update for 2010 U.S. Army Medical Command Fort Sam Houston, TX Describe most recent changes in The Joint Commission (TJC) Accreditation Program
More informationIdentifying Errors: A Case for Medication Reconciliation Technicians
Organization: Solution Title: Calvert Memorial Hospital Identifying Errors: A Case for Medication Reconciliation Technicians Program/Project Description and Goals: What was the problem to be solved? To
More informationPOLICY AND PROCEDURE DEPARTMENT: Pharmacy Operations
PAGE: 1 of 6 SCOPE: Centene Corporate Pharmacy Department, Centene Corporate Pharmacy and Therapeutics Committee, Health Plan Pharmacy Departments, Health Plan Pharmacy and Therapeutics Committees, and
More informationSession 2 Improving Narcotics and Opiate Management
Session 2 Improving Narcotics and Opiate Management Frank Federico, RPh, IHI Executive Director Steve Meisel, Pharm.D., IHI Faculty January 31,2012 12:00-1:00pm ET Beth O Donnell, MPH Beth O Donnell, MPH,
More informationCase Study from Parallon
Case Study from Parallon Improving Compliance with the Smart Pump drug library across a large hospital system Part 2 Monday, July 10, 2017 AAMI Foundation Vision: To drive the safe adoption and safe use
More informationPGY-1 Pharmacy Practice
Lutheran Health Network PGY-1 Pharmacy Practice Residency Program LHN Pharmacy Residency Program Mission Statement The mission of the LHN Pharmacy Residency Program is to empower pharmacy residents to
More informationThe Role of the Agency for Healthcare Research and Quality (AHRQ) in the US Drug Safety System
The Role of the Agency for Healthcare Research and Quality (AHRQ) in the US Drug Safety System Scott R. Smith, MSPH, PhD Center for Outcomes & Evidence Agency for Healthcare Research & Quality July 20,
More informationMedication Safety in the Operating Room: Using the Operating Room Medication Safety Checklist
Medication Safety in the Operating Room: Using the Operating Room Medication Safety Checklist CPSI Safe Surgery Saves Lives Workshop Montréal, QC 29Mar2011 Julie Greenall, RPh, BScPhm, MHSc, FISMPC Institute
More informationLicensed Pharmacy Technicians Scope of Practice
Licensed s Scope of Practice Adapted from: Request for Regulation of s Approved by Council April 24, 2015 DEFINITIONS In this policy: Act means The Pharmacy and Pharmacy Disciplines Act means an unregulated
More informationCPhT Program Recognition Attestation Form
About this Form Beginning in 2020, CPhT applicants must have completed a PTCB-recognized education/training program or have equivalent work experience in order to be eligible for certification. The purpose
More informationPHCY 471 Community IPPE. Student Name. Supervising Preceptor Name(s)
PRECEPTOR CHECKLIST /SIGN-OFF PHCY 471 Community IPPE Student Name Supervising Name(s) INSTRUCTIONS The following table outlines the primary learning goals and activities for the Community IPPE. Each student
More informationMEDMARX ADVERSE DRUG EVENT REPORTING
MEDMARX ADVERSE DRUG EVENT REPORTING Comparative Performance Reporting Helps to Reduce Adverse Drug Events Are you getting the most out of your adverse drug event (ADE) data? ADE reporting initiatives
More informationHallmarks of Patient Safety and Quality Improvement Programs in Pharmacy Practice
Hallmarks of Patient Safety and Quality Improvement Programs in Pharmacy Practice Jordan T. Daniel, PharmD Wednesday, May 10, 2017 Kimberly McDonough Spring Seminar Rhode Island Pharmacy Foundation Disclosure
More informationSteps Taken to Combat the Opiate Epidemic Through Legal And Technological Channels. Nick Snyder, Esq.
Steps Taken to Combat the Opiate Epidemic Through Legal And Technological Channels Nick Snyder, Esq. How Can We Impact Inappropriate Over-Prescribing of Opioids in Maine? What have other States or Organizations
More informationPolicies Approved by the 2017 ASHP House of Delegates
House of Delegates Policies Approved by the 2017 ASHP House of Delegates 1701 Ensuring Patient Safety and Data Integrity During Cyber-attacks Source: Council on Pharmacy Management To advocate that healthcare
More informationPOLICY AND PROCEDURE DEPARTMENT: Pharmacy Operations
PAGE: 1 of 5 SCOPE: Centene Corporate Pharmacy Solutions, Centene Corporate Pharmacy and Therapeutics Committee, Health Plan Pharmacy Departments, Health Plan Pharmacy and Therapeutics Committees, Pharmacy
More informationALLIED PHYSICIAN IPA ADVANTAGE HEALTH NETWORK IPA ARROYO VISTA MEDICAL IPA GREATER ORANGE MEDICAL GROUP IPA GREATER SAN GABRIEL VALLEY PHYSICIANS IPA
ALLIED PHYSICIAN IPA ADVANTAGE HEALTH NETWORK IPA ARROYO VISTA MEDICAL IPA GREATER ORANGE MEDICAL GROUP IPA GREATER SAN GABRIEL VALLEY PHYSICIANS IPA QUALITY IMPROVEMENT PROGRAM 2010 Overview The Quality
More informationADMINISTRATIVE POLICY & PROCEDURE PATIENT SAFETY PLAN
PAGE #: 1 of 6 CROSS REFERENCES: Administrative Policy PI-01: Administrative Policy PI-03: Administrative Policy RI-20: Administrative Policy EC-25: Sentinel Event Risk Management Plan Guidelines for Disclosure
More informationE.H.R. s and Improving Patient Safety - What Has Been the Real Impact?
E.H.R. s and Improving Patient Safety - What Has Been the Real Impact? Presented by: Mary Erickson, RN, HTS Accounting Manager HTS, a division of Mountain Pacific Quality Health Foundation 1 Understand
More informationPRE-SURVEY QUESTIONNAIRE AND SELF-ASSESSMENT CHECKLIST FOR ACCREDITATION OF: POSTGRADUATE YEAR ONE (PGY1) COMMUNITY PHARMACY RESIDENCY PROGRAMS
PRE-SURVEY QUESTIONNAIRE AND SELF-ASSESSMENT CHECKLIST FOR ACCREDITATION OF: POSTGRADUATE YEAR ONE (PGY1) COMMUNITY PHARMACY RESIDENCY PROGRAMS PURPOSE The pre-survey questionnaire serves to maximize the
More informationAPEx Program Standards
APEx Program Standards The following standards are the basis of the APEx program. Level 1 standards are indicated in bold. Standard 1: Patient Evaluation, Care Coordination and Follow-up The radiation
More informationPolicy Statement Medication Order Legibility Medication orders will be written in a manner that provides a clearly legible prescription.
POLICY POLICY PURPOSE: The purpose of this policy is to provide a foundation for safe communication of medication and nutritional orders in-scope, thereby reducing the potential for preventable medication
More informationMedication Safety Issues and Recommended Strategies Related to Sterile Compounding PharMEDium Lunch and Learn Series LUNCH AND LEARN
LUNCH AND LEARN Medication Safety Issues and Recommended Strategies Related to Sterile Compounding January 12, 2018 Featured Speaker: Christina Michalek, BS, RPh, FASHP Medication Safety Specialist Institute
More informationOctober 11 13, 2018 Dallas, TX Poster Submission Rules & Format t Guidelines
October 11 13, 2018 Dallas, TX Poster Subm mission Rule es & Format Guid delines 2018 American Society of Health System Pharmacists, Inc. ASHP is a service mark of the American Society of Health System
More informationN ATIONAL Q UALITY F ORUM. Safe Practices for Better Healthcare 2006 Update A CONSENSUS REPORT
N ATIONAL Q UALITY F ORUM Safe Practices for Better Healthcare 2006 Update A CONSENSUS REPORT NATIONAL QUALITY FORUM Foreword Every person who seeks care in a healthcare facility should expect to receive
More informationThanks to Anne C. Byrne, RN, Medical Monitor at Northwest Georgia Regional Hospital. This presentation was developed from one she designed for that
Thanks to Anne C. Byrne, RN, Medical Monitor at Northwest Georgia Regional Hospital. This presentation was developed from one she designed for that hospital. 1 2 3 Note that an actual variance occurs when
More information